IL6 and ovarian carcinoma: Since then, a paracrine circuit involving IL-6, which increases the levels of fibrinogen and thromboplastin thereby causing thrombocytosis, has been found to be associated with increased thrombotic risk in patients with ovarian cancer and other neoplasms.